Anacetrapib, also known as MK-0859, is a CETP inhibitor being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.
相关文献及参考
Krishna, R. et al.: Br. J. Clin. Pharmacol., 67, 520 (2009); Vergeer, M. et al.: Nat. Clin. Pract. Cardiovasc. Med., 5, 302 (2008); Masson, D.: Curr. Opin. Invest. Drugs, 10, 980 (2009);
安全信息
Storage condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).